Fundraising FoxJMI Equity — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Imara is a clinical-stage biopharmaceutical company developing small molecule therapeutics for unmet medical needs, currently advancing ELVN-001, a selective kinase inhibitor designed to treat chronic myeloid leukemia by targeting the BCR-ABL gene fusion.
BiotechCambridge, US
James G. McArthur(Executive Officer, Director)Christoph M. Adams(Executive Officer, Director)Richard Fair(President, Chief Executive Officer, Director)
BoardSara Nayeem(Director)Barbara Dalton(Director)David Mott(Director)
Co-investorsBay City CapitalNew Enterprise Associates (NEA)Pfizer Venture InvestmentsRA CapitalAlexandriaArix Bioscience+3 more
Lytics is a customer data platform for building and using unified customer profiles.
AI & Machine LearningData & InfrastructureMarketing TechSaaSPortland, US
Aaron Raddon(Executive Officer, Director)inJames McDermott(CEO)inDrew Lanenga(CTO)inDan Abelon(Director)
BoardScott Irwin(Director)inBrett Queener(Director)in
Co-investorsComcast VenturesVoyager CapitalEPIC VENTURESR/GA VenturesRembrandt Venture PartnersBonfire Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.